A Study of Doripenem in Infants Less Than 12 Weeks of Age

NCT01381848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: Doripenem
DRUG: Doripenem

Sponsor

Janssen Research & Development, LLC